Looking for a Growth Stock? 3 Reasons Why BioMarin (BMRN) is a Solid Choice
In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.
However, it's pretty easy to find cutting-edge growth stocks with the help of the Zacks Growth Style Score (part of the Zacks Style Scores system), which looks beyond the traditional growth attributes to analyze a company's real growth prospects.
BioMarin Pharmaceutical (BMRN) is on the list of such stocks currently recommended by our proprietary system. In addition to a favorable Growth Score, it carries a top Zacks Rank.
Studies have shown that stocks with the best growth features consistently outperform the market. And for stocks that have a combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy), returns are even better.
Here are three of the most important factors that make the stock of this rare disease biopharmaceutical a great growth pick right now.
Earnings Growth
Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. For growth investors, double-digit earnings growth is highly preferable, as it is often perceived as an indication of strong prospects (and stock price gains) for the company under consideration.
While the historical EPS growth rate for BioMarin is 40.9%, investors should actually focus on the projected growth. The company's EPS is expected to grow 23% this year, crushing the industry average, which calls for EPS growth of 19.7%.
Cash Flow Growth
Cash is the lifeblood of any business, but higher-than-average cash flow growth is more beneficial and important for growth-oriented companies than for mature companies. That's because, high cash accumulation enables these companies to undertake new projects without raising expensive outside funds.
Right now, year-over-year cash flow growth for BioMarin is 83.6%, which is higher than many of its peers. In fact, the rate compares to the industry average of -4.7%.
While investors should actually consider the current cash flow growth, it's worth taking a look at the historical rate too for putting the current reading into proper perspective. The company's annualized cash flow growth rate has been 40.1% over the past 3-5 years versus the industry average of 4.1%.
Promising Earnings Estimate Revisions
Beyond the metrics outlined above, investors should consider the trend in earnings estimate revisions. A positive trend is a plus here. Empirical research shows that there is a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The current-year earnings estimates for BioMarin have been revising upward. The Zacks Consensus Estimate for the current year has surged 0.1% over the past month.
Bottom Line
BioMarin has not only earned a Growth Score of B based on a number of factors, including the ones discussed above, but it also carries a Zacks Rank #1 because of the positive earnings estimate revisions.
You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
This combination indicates that BioMarin is a potential outperformer and a solid choice for growth investors.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BioMarin Pharmaceutical Inc. (BMRN) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
6 hours ago
- Yahoo
Are Basic Materials Stocks Lagging Barrick Mining Corporation (B) This Year?
The Basic Materials group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Barrick Mining (B) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Basic Materials sector should help us answer this question. Barrick Mining is a member of the Basic Materials sector. This group includes 238 individual stocks and currently holds a Zacks Sector Rank of #13. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Barrick Mining is currently sporting a Zacks Rank of #1 (Strong Buy). The Zacks Consensus Estimate for B's full-year earnings has moved 18.2% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger. Based on the latest available data, B has gained about 36.1% so far this year. In comparison, Basic Materials companies have returned an average of 9.7%. As we can see, Barrick Mining is performing better than its sector in the calendar year. One other Basic Materials stock that has outperformed the sector so far this year is Newmont Corporation (NEM). The stock is up 67.4% year-to-date. Over the past three months, Newmont Corporation's consensus EPS estimate for the current year has increased 31.2%. The stock currently has a Zacks Rank #1 (Strong Buy). Looking more specifically, Barrick Mining belongs to the Mining - Gold industry, which includes 39 individual stocks and currently sits at #43 in the Zacks Industry Rank. Stocks in this group have gained about 53% so far this year, so B is slightly underperforming its industry this group in terms of year-to-date returns. Newmont Corporation is also part of the same industry. Going forward, investors interested in Basic Materials stocks should continue to pay close attention to Barrick Mining and Newmont Corporation as they could maintain their solid performance. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Barrick Mining Corporation (B) : Free Stock Analysis Report Newmont Corporation (NEM) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
10 hours ago
- Yahoo
A Dream Combination: 3 Value Stocks with Growth
(0:30) - Stock Screener: Can You Find Strong Value Stocks With Growth? (6:45) - Tracey's Top Stock Picks (22:25) - Episode Roundup: ADDYY, ARRY, NX Podcast@ Welcome to Episode #413 of the Value Investor Podcast. Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks. Growth stocks continue to rally. This usually depresses value investors who think they can't be in that trade. But what if they could? What if value investors could buy cheap stocks that also have growth? Screening for Value Stocks with Growth There's one key metric value investors can rely on to find value plus growth and that is the PEG ratio. The PEG ratio, first utilized by Warren Buffett's boss and mentor, Benjamin Graham, uses the price-to-earnings (P/E) ratio divided by earnings growth. Investors get the best of both worlds, both value and growth, with one ratio. The PEG must be below 1.0 to get the cheapest stocks. Tracey also added the top Zacks Ranks of #1 (Strong Buy) and #2 (Buy) and screened for stocks over $5 so as to not get any penny stocks. The screen also looks for current average broker recommendations of 2.5 and under. This screen returned 19 matches. 3 Value Stocks with Growth 1. Adidas AG (ADDYY) Adidas, the large cap athletic shoe and apparel company, is expected to see earnings grow 88.3% in 2025 and 47.3% in 2026. Why are Adidas shares down 17.6% over the last 5 sessions? The shoe retailers are facing tariff risks and the possibility of a consumer slowdown. Adidas' price-to-earnings (P/E) ratio isn't as low as others. It's trading at 26x. But with that big growth, the PEG is still low, at 0.5. Is Adidas a deal after this sell-off? 2. Quanex Building Products Corp. (NX) Quanex Building Products is a small cap company with a mark cap of $918 million. It manufactures products for the building industry, both residential and commercial, including doors and windows. Earnings for Quanex are expected to rise 19.6% in 2025 and another 14.1% in 2026. Shares have come down 18.8% year-to-date as building has slowed. With a forward P/E of just 7.4, Quanex has a PEG ratio of 0.5. Quanex also pays a dividend, yielding 1.6%. Should a small cap company like Quanex be on your short list? 3. Array Technologies, Inc. (ARRY) Array Technologies is a small cap company which makes solar tracking technology. The solar industry has been uncertain in 2025 with tariffs and changes to solar incentives. Shares of Array Technologies have fallen 11.7% in the last week. Year-to-date it's up 1%. But earnings are expected to be up 10% in 2025 and 35% in 2026. Array has a low P/E of just 9.9. A P/E ratio under 10 usually indicates a company is dirt cheap. With the expected growth, it has a PEG ratio of 0.46. Should value investors take a chance on Array Technologies? What Else Should You Know About Value Stocks with Growth? Tune into this week's podcast to find out. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Adidas AG (ADDYY) : Free Stock Analysis Report Quanex Building Products Corporation (NX) : Free Stock Analysis Report Array Technologies, Inc. (ARRY) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
12 hours ago
- Yahoo
Synopsys (SNPS) Falls More Steeply Than Broader Market: What Investors Need to Know
Synopsys (SNPS) closed the most recent trading day at $633.47, moving -1.84% from the previous trading session. The stock fell short of the S&P 500, which registered a loss of 0.37% for the day. At the same time, the Dow lost 0.74%, and the tech-heavy Nasdaq lost 0.03%. The maker of software used to test and develop chips's shares have seen an increase of 23.37% over the last month, surpassing the Computer and Technology sector's gain of 4.58% and the S&P 500's gain of 2.68%. Analysts and investors alike will be keeping a close eye on the performance of Synopsys in its upcoming earnings disclosure. The company's earnings report is set to go public on September 9, 2025. It is anticipated that the company will report an EPS of $3.84, marking a 11.95% rise compared to the same quarter of the previous year. Simultaneously, our latest consensus estimate expects the revenue to be $1.77 billion, showing a 15.9% escalation compared to the year-ago quarter. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $15.09 per share and revenue of $6.77 billion. These totals would mark changes of +14.32% and +8.03%, respectively, from last year. Investors should also note any recent changes to analyst estimates for Synopsys. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Hence, positive alterations in estimates signify analyst optimism regarding the business and profitability. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 0.03% lower. Synopsys is currently sporting a Zacks Rank of #3 (Hold). With respect to valuation, Synopsys is currently being traded at a Forward P/E ratio of 42.77. This valuation marks a premium compared to its industry average Forward P/E of 25.14. It is also worth noting that SNPS currently has a PEG ratio of 3.06. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Computer - Software industry had an average PEG ratio of 2.33. The Computer - Software industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 46, this industry ranks in the top 19% of all industries, numbering over 250. The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Be sure to use to monitor all these stock-influencing metrics, and more, throughout the forthcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Synopsys, Inc. (SNPS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
